Peptide for augmenting and expression of BDNF and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including Alzheimer's disease or Parkinson's disease, comprising the same
US 8,557,960 Lapsed on the fee recordLapsed Oct 15, 2025 on the fee record · From the USPTO record
20-year base term ends Dec 31, 2029
Third maintenance fee unpaid; grace period ended.
Dec 31, 2009
Oct 15, 2025
Oct 15, 2013
Dec 31, 2029
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 31, 2009, when this application, 12/934,029, was filed | Dec 31, 2029 | USPTO record |
| Continuity chain | Every parent in the chain resolved | no change | USPTO record |
| Patent term adjustment | No term adjustment record on a grant after 2005, so none is added | no change | USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | USPTO record |
| Patent term extension | None on file | no change | USPTO record |
| Fee events | 2 of 3 maintenance fees paid | lapsed Oct 15, 2025 | USPTO record |
| Computed term end | The steps above, in order | Oct 15, 2025 | USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.